A comprehensive systematic review of testicular germ cell tumor surveillance

被引:126
作者
Groll, R. J.
Warde, P.
Jewett, M. A. S.
机构
[1] Univ Toronto, Univ Hlth Network, Div Urol, Dept Surg, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Univ Hlth Network, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
关键词
testicular cancer; surveillance; review; systematic;
D O I
10.1016/j.critrevonc.2007.04.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Testicular cancer is the most common malignancy in men aged 15-34, and its incidence has been increasing over the past half-century. Survival for stage I testis cancer approaches 100% regardless of management strategy which is often dictated by other factors, such as perceived morbidity. Advances in treatment have attempted to decrease morbidity and surveillance is thought to achieve this goal. Methods: An English language literature search of MEDLINE from 1966 to December 2005 and CINAHL from 1982 to December 2005 was conducted using a broad search strategy. Comparative and descriptive original articles on Outcomes of seminoma or NSGCT surveillance would be deemed eligible and review articles containing no original data were omitted. One hundred and thirty-eight articles were selected for formal review, during which a database was compiled that documented the first author, publication year, tumor histologic type, study purpose or topic(s), methodology, sample size, median follow-up, and relevant results. Results: Most evidence for the efficacy of surveillance is from descriptive series or non-experimental comparative studies. Relapse occurs in approximately 28% and 17% of surveillance patients in NSGCT and seminoma, respectively, and cause-specific survival is approximately 98% and 100%, respectively. Compliance with surveillance ranges from poor to adequate, however there is no evidence that compliance impacts clinical outcome. Cost analyses have yielded inconsistent results when comparing treatment modalities. There is scant literature on quality of life and psychosocial issues and results are inconsistent. Active surveillance appears to be appropriate and perhaps optimal first line management of clinical stage I seminoma and non-seminomatous germ cell tumors. Further quantitative and qualitative research is warranted to deepen understanding of these issues that may impact treatment decision-making. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:182 / 197
页数:16
相关论文
共 109 条
[1]   Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial [J].
Albers, P ;
Siener, R ;
Kliesch, S ;
Weissbach, L ;
Krege, S ;
Sparwasser, C ;
Schulze, H ;
Heidenreich, A ;
de Riese, W ;
Loy, V ;
Bierhoff, E ;
Wittekind, C ;
Fimmers, R ;
Hartmann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1505-1512
[2]   Stage I non-seminomatous germ-cell tumours of the testis:: identification of a subgroup of patients with a very low risk of relapse [J].
Alexandre, J ;
Fizazi, K ;
Mahé, C ;
Culine, S ;
Droz, JP ;
Théodore, C ;
Terrier-Lacombe, MJ .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) :576-582
[3]   STAGE-1 SEMINOMA OF THE TESTIS - ADJUVANT RADIOTHERAPY OR SURVEILLANCE [J].
ALLHOFF, EP ;
LIEDKE, S ;
DERIESE, W ;
STIEF, C ;
SCHNEIDER, B .
BRITISH JOURNAL OF UROLOGY, 1991, 68 (02) :190-194
[4]   Sexuality and fertility in long-term survivors of testicular cancer [J].
Arai, Y ;
Kawakita, M ;
Okada, Y ;
Yoshida, O .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1444-1448
[5]   Psychosocial aspects in long-term survivors of testicular cancer [J].
Arai, Y ;
Kawakita, M ;
Hida, S ;
Terachi, T ;
Okada, Y ;
Yoshida, O .
JOURNAL OF UROLOGY, 1996, 155 (02) :574-578
[6]   A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours [J].
Atsü, N ;
Eskiçorapçi, S ;
Üner, A ;
Ekici, S ;
Güngen, Y ;
Erkan, I ;
Uygur, MC ;
Özen, H .
BJU INTERNATIONAL, 2003, 92 (01) :32-35
[7]  
Bagnell Scott, 2004, Can J Urol, V11, P2194
[8]   Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors [J].
Baniel, J ;
Roth, BJ ;
Foster, RS ;
Donohue, JP .
ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (01) :86-93
[9]   Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon [J].
Bergstrom, R ;
Adami, HO ;
Mohner, M ;
Zatonski, W ;
Storm, H ;
Ekbom, A ;
Tretli, S ;
Teppo, L ;
Akre, O ;
Hakulinen, T .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (11) :727-733
[10]  
BLACKMORE C, 1988, CANCER NURS, V11, P33